acox-1.5 Antibody

What is ACOX1 and why is it an important target for antibody-based research?

ACOX1 (peroxisomal acyl-coenzyme A oxidase 1) is a crucial enzyme involved in the initial and rate-limiting step of peroxisomal beta-oxidation of straight-chain saturated and unsaturated very-long-chain fatty acids. This 660 amino acid protein is primarily localized in the peroxisome, where it catalyzes the desaturation of fatty acyl-CoAs such as palmitoyl-CoA to 2-trans-enoyl-CoAs. During this reaction, ACOX1 donates electrons directly to molecular oxygen, producing hydrogen peroxide as a byproduct. The enzyme plays a vital role in lipid metabolism and energy production, with its dysfunction linked to serious conditions including pseudoneonatal adrenoleukodystrophy (pseudo-NALD), characterized by neurological impairments and metabolic dysfunctions . Research targeting ACOX1 is significant for understanding fundamental cellular processes, metabolic disorders, and potential therapeutic interventions for related pathologies.

What validation methods should be employed before using an ACOX1 antibody in critical research applications?

Before employing an ACOX1 antibody in definitive experiments, comprehensive validation is essential. First, perform Western blotting using positive and negative control samples (tissues or cell lines with known ACOX1 expression levels), confirming the antibody detects a band at the expected molecular weight (approximately 74 kDa for human ACOX1). Second, validate antibody specificity using ACOX1 knockdown cells, as demonstrated in studies where shRNA targeting ACOX1 successfully reduced expression . Third, conduct cross-reactivity testing across species if planning multi-species studies, as antibody recognition can vary significantly. Fourth, perform immunoprecipitation followed by mass spectrometry to confirm the antibody's ability to specifically pull down ACOX1. Finally, include appropriate controls in all experiments, such as secondary antibody-only controls for immunofluorescence and isotype controls for flow cytometry applications. This methodical validation approach ensures reliable and reproducible results across experimental platforms.

How can researchers distinguish between active and inactive forms of ACOX1 using antibody-based techniques?

Distinguishing between active and inactive ACOX1 forms requires specialized approaches combining antibody techniques with functional assessments. Research indicates that ACOX1 activity correlates strongly with its dimerization status and post-translational modifications, particularly lysine succinylation . To detect active ACOX1 dimers, employ glutaraldehyde cross-linking followed by immunoblotting, which preserves protein-protein interactions during sample preparation. Apply 0.025% glutaraldehyde for 5 minutes at room temperature to cross-link dimeric ACOX1 before standard Western blotting procedures . Alternatively, use antibodies specifically recognizing succinylated ACOX1, as succinylation promotes active dimer formation. Cross-correlate immunoblotting results with direct enzyme activity assays measuring hydrogen peroxide production using Amplex Red reagent. For in situ activity assessment, combine immunofluorescence with proximity ligation assays (PLA) to visualize ACOX1 dimers within intact cells. This multi-faceted approach provides a comprehensive assessment of ACOX1's activation state beyond mere protein expression levels.

What is the recommended protocol for measuring ACOX1 enzyme activity in conjunction with antibody-based protein quantification?

To comprehensively analyze ACOX1 in experimental systems, combine antibody-based protein quantification with functional enzyme activity measurement. Begin by immunoprecipitating ACOX1 from cell or tissue lysates using a validated antibody bound to protein A/G beads or anti-Flag resin for tagged constructs. Elute the isolated protein with appropriate peptide and immediately perform the activity assay to prevent degradation . For the enzyme activity measurement, utilize a reaction mixture containing 25 mM Tris-HCl (pH 8.0), 1 mM MgCl₂, 200 mM NaCl, 5 mM KCl, 0.1% PEG8000, and a suitable fatty acyl-CoA substrate such as palmitoyl-CoA . Quantify hydrogen peroxide production, which directly correlates with ACOX1 activity, using fluorometric detection with Amplex Red reagent (excitation at 530-560 nm, emission at 590 nm). In parallel, perform Western blotting with an aliquot of the immunoprecipitated sample to determine the amount of ACOX1 protein present. Calculate specific enzyme activity by normalizing the rate of hydrogen peroxide production to the amount of ACOX1 protein, thus enabling accurate comparisons across experimental conditions.

How can researchers address non-specific binding when using ACOX1 antibodies in tissues with high lipid content?

When working with lipid-rich tissues such as liver, brain, or adipose tissue, non-specific binding of ACOX1 antibodies presents a significant challenge. This issue arises because hydrophobic interactions between antibodies and lipids can mask true ACOX1 signals. To overcome this, implement a comprehensive blocking strategy using 5% non-fat dry milk or 3% BSA supplemented with 0.1% Triton X-100 for at least 2 hours at room temperature . For particularly problematic samples, add 0.1-0.3% SDS to disrupt hydrophobic interactions during the antigen retrieval step. Additionally, pre-absorb the primary antibody with tissue homogenate from ACOX1 knockout models or with tissue treated with ACOX1-targeted shRNA to remove antibodies recognizing non-ACOX1 epitopes . For immunohistochemistry applications, optimize antigen retrieval using citrate buffer (pH 6.0) with microwave heating for 10 minutes before antibody incubation . Always include negative controls lacking primary antibody and positive controls with known ACOX1 expression to accurately interpret staining patterns. These methodological refinements substantially improve signal-to-noise ratio in challenging lipid-rich tissues.

What experimental controls are essential when investigating ACOX1 post-translational modifications using specific antibodies?

Rigorous controls are critical when studying ACOX1 post-translational modifications, particularly succinylation which regulates its enzymatic activity. First, include samples from cells treated with SIRT5 knockdown (which increases ACOX1 succinylation) alongside wild-type controls to establish modification detection sensitivity . Second, employ both wild-type ACOX1 and site-specific mutants where lysine residues susceptible to succinylation are replaced with arginine (maintaining positive charge but preventing modification). Third, validate antibody specificity using competition assays with free modified peptides containing the modification of interest. Fourth, include samples treated with succinyl-CoA (0.1 mM) which increases succinylation levels and should correlate with enhanced ACOX1 activity (approximately 1.7-fold increase) . Fifth, perform parallel functional assays measuring ACOX1 enzyme activity to correlate modification status with functional outcomes. For mass spectrometry validation, immunoprecipitate ACOX1 under native conditions and verify modification sites using high-resolution MS/MS fragmentation patterns. This comprehensive control strategy ensures accurate interpretation of ACOX1 post-translational modification data.

How should researchers reconcile conflicting data between antibody-based detection and mRNA expression levels of ACOX1?

Discrepancies between ACOX1 protein levels (detected by antibodies) and mRNA expression are commonly encountered and require systematic investigation. First, verify antibody specificity using ACOX1 knockdown models to confirm the detected bands genuinely represent ACOX1 . Second, consider post-transcriptional regulation mechanisms – ACOX1 mRNA contains regulatory elements in its untranslated regions that can affect translation efficiency independent of transcript abundance. Third, examine protein stability factors; ACOX1 has a half-life of approximately 24-48 hours in hepatocytes, but this may vary across cell types or disease states. Fourth, investigate post-translational modifications, particularly succinylation which affects ACOX1 stability and may not correlate with transcript levels . Fifth, assess subcellular fractionation quality, as ACOX1's peroxisomal localization requires proper fractionation techniques for accurate quantification. Construct a time-course experiment measuring both mRNA (by qRT-PCR) and protein (by Western blotting) following perturbation to characterize the temporal relationship between transcript and protein changes. This structured approach helps resolve apparent contradictions and provides deeper insight into ACOX1 regulation mechanisms.

How can ACOX1 antibodies be utilized to investigate the relationship between peroxisomal function and mitochondrial metabolism?

ACOX1 antibodies offer powerful tools for exploring peroxisome-mitochondria metabolic crosstalk. Implement a dual immunofluorescence approach using anti-ACOX1 antibodies alongside mitochondrial markers (TOMM20 or MitoTracker dyes) to visualize spatial relationships between these organelles under various metabolic conditions . Quantify co-localization using Pearson's or Mander's coefficients across different metabolic states (fed, fasted, or specific substrate challenges). For biochemical interaction studies, perform proximity ligation assays (PLA) using ACOX1 antibodies paired with antibodies against mitochondrial fatty acid oxidation enzymes to detect potential protein-protein interactions at organelle contact sites. To investigate metabolic flux, combine ACOX1 immunoprecipitation with activity assays measuring hydrogen peroxide production under conditions that modulate mitochondrial function (such as respiratory chain inhibitors or uncouplers). Correlate these findings with measurements of oxidative stress markers, as ACOX1-generated hydrogen peroxide contributes significantly to cellular redox balance. This integrated approach reveals how peroxisomal beta-oxidation initiated by ACOX1 coordinates with mitochondrial metabolism, providing insight into conditions like non-alcoholic fatty liver disease where both organelles' functions are dysregulated.

What are the considerations for using ACOX1 antibodies in studying the role of peroxisomal oxidative stress in neurodegeneration?

When investigating ACOX1's role in neurodegeneration, researchers must carefully select and apply antibodies appropriate for neural tissues. Begin by validating antibody specificity in neural cell types, as ACOX1 expression patterns differ significantly between neurons, astrocytes, and oligodendrocytes. For human post-mortem brain tissue studies, optimize antigen retrieval methods (10 minutes microwave heating in citrate buffer, pH 6.0) to overcome fixation-induced epitope masking . Employ dual immunofluorescence with ACOX1 antibodies and cell-type-specific markers (NeuN for neurons, GFAP for astrocytes) to identify cell populations with altered ACOX1 expression in disease states. To investigate oxidative stress contributions, combine ACOX1 immunostaining with detection of oxidative damage markers (8-OHdG or 4-HNE) and antioxidant response elements (such as Nrf2 nuclear translocation). For mechanistic studies in cellular models, use ACOX1 antibodies to monitor protein levels following genetic manipulation of antioxidant pathways or exposure to disease-relevant stressors such as amyloid-β or α-synuclein. This comprehensive approach elucidates how peroxisomal ACOX1 activity and associated hydrogen peroxide production contribute to oxidative stress mechanisms underlying neurodegenerative pathology.

How can researchers utilize ACOX1 antibodies to investigate the regulation of its enzymatic activity by SIRT5-mediated desuccinylation?

Investigating SIRT5's regulation of ACOX1 requires sophisticated antibody applications beyond conventional detection methods. First, employ co-immunoprecipitation using anti-ACOX1 antibodies followed by Western blotting for SIRT5 to establish physiological interaction between these proteins in different metabolic states . For succinylation analysis, use anti-succinyl-lysine antibodies on immunoprecipitated ACOX1 to monitor modification levels in response to SIRT5 manipulation. Design experiments comparing wild-type conditions to SIRT5 knockdown or knockout models, which typically exhibit increased ACOX1 activity (approximately 1.5 to 1.9-fold elevation) correlating with enhanced succinylation . For mechanistic studies on ACOX1 dimerization, which is promoted by succinylation, perform glutaraldehyde cross-linking (0.025% concentration) followed by immunoblotting to visualize dimeric versus monomeric forms under various SIRT5 activity conditions . In cellular models, combine these biochemical approaches with functional assays measuring hydrogen peroxide production and oxidative stress markers. The research by Ding et al. demonstrated that SIRT5 knockdown increases ACOX1 succinylation, promotes dimerization, and enhances enzymatic activity - effects that were absent when using catalytically inactive SIRT5 (H158Y mutant) . This multifaceted approach reveals how metabolic sensors like SIRT5 dynamically regulate peroxisomal oxidative metabolism through post-translational modifications of ACOX1.

What methodological approaches allow for quantitative assessment of ACOX1 dimerization in relation to enzyme activity?

Quantifying ACOX1 dimerization in relation to its activity requires integrating several specialized techniques. Begin with glutaraldehyde cross-linking at 0.025% concentration for precisely 5 minutes at room temperature to stabilize dimeric ACOX1 while minimizing non-specific aggregation . Separate the cross-linked proteins using gradient gels (4-12%) to achieve optimal resolution between monomeric (~74 kDa) and dimeric (~148 kDa) ACOX1 forms. Quantify the dimer/monomer ratio by densitometric analysis of immunoblots using ACOX1 antibodies. In parallel, measure ACOX1 enzymatic activity using palmitoyl-CoA or decanoyl-CoA as substrates, quantifying hydrogen peroxide production via the Amplex Red assay. Calculate the correlation coefficient between dimerization ratio and enzymatic activity across experimental conditions. For in situ visualization of dimers, implement proximity ligation assays using two distinct ACOX1 antibodies recognizing different epitopes, generating fluorescent signals only when ACOX1 proteins are in close proximity (dimeric form). Research by Ding et al. demonstrated that enhanced ACOX1 dimerization correlates significantly with increased enzymatic activity, particularly under conditions of elevated succinylation when SIRT5 activity is reduced . This quantitative approach reveals structural transitions that directly impact ACOX1's functional capacity in fatty acid oxidation.

How can researchers develop reliable immunohistochemistry protocols for ACOX1 detection in formalin-fixed, paraffin-embedded liver biopsy specimens?

Developing reliable immunohistochemistry protocols for ACOX1 in FFPE liver biopsies requires methodical optimization due to the high lipid content and metabolic heterogeneity of liver tissue. Begin with deparaffinization using xylene (three 5-minute washes) followed by rehydration through graded alcohols to water. Critical for ACOX1 detection is the antigen retrieval step - optimize using citrate buffer (10 mM, pH 6.0) with microwave heating for precisely 10 minutes, as excessive heating may disrupt tissue morphology while insufficient heating prevents adequate epitope exposure . Block endogenous peroxidase activity with 3% hydrogen peroxide for 30 minutes . Implement a stringent blocking procedure using 5% goat serum with 0.3% Triton X-100 in PBS for 1-2 hours at room temperature to minimize non-specific binding . Apply validated ACOX1 primary antibodies at optimized dilutions (typically 1:500 for monoclonal antibodies) and incubate overnight at 4°C . For detection, employ HRP-conjugated secondary antibodies with DAB development carefully timed to maximize signal-to-noise ratio. Include positive controls (normal liver) and negative controls (primary antibody omission and ACOX1-depleted tissues) in each staining batch. This protocol enables reliable ACOX1 visualization in periportal to pericentral hepatocytes, revealing zonal expression patterns relevant to metabolic zonation in normal and pathological liver conditions.